INVESTOR’S BUSINESS DAILY Gets It

This editorial from Investor’s Business Daily is right on the money. Tremeondous progress is being made in adult/umbilical cord blood stem cells (which is why it gets more private funding), all but ignored by the media in their obsession to defeat the “heartless right wing Bible thumpers.” Good for IBD for seeing through the cloning obfuscation.